- Home
- CDXS vs NETD Comparison
CDXS vs NETD Comparison
Compare CDXS & NETD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- NETD
- Stock Information
- Founded
- CDXS 2002
- NETD 2023
- Country
- CDXS United States
- NETD United States
- Employees
- CDXS N/A
- NETD N/A
- Industry
- CDXS Major Chemicals
- NETD
- Sector
- CDXS Industrials
- NETD
- Exchange
- CDXS Nasdaq
- NETD Nasdaq
- Market Cap
- CDXS 216.6M
- NETD 242.3M
- IPO Year
- CDXS 2010
- NETD 2023
- Fundamental
- Price
- CDXS $2.09
- NETD $11.35
- Analyst Decision
- CDXS Buy
- NETD
- Analyst Count
- CDXS 2
- NETD 0
- Target Price
- CDXS $11.00
- NETD N/A
- AVG Volume (30 Days)
- CDXS 656.9K
- NETD 247.2K
- Earning Date
- CDXS 11-06-2025
- NETD 01-01-0001
- Dividend Yield
- CDXS N/A
- NETD N/A
- EPS Growth
- CDXS N/A
- NETD N/A
- EPS
- CDXS N/A
- NETD 0.29
- Revenue
- CDXS $57,164,000.00
- NETD N/A
- Revenue This Year
- CDXS $12.88
- NETD N/A
- Revenue Next Year
- CDXS $21.64
- NETD N/A
- P/E Ratio
- CDXS N/A
- NETD $38.45
- Revenue Growth
- CDXS N/A
- NETD N/A
- 52 Week Low
- CDXS $1.90
- NETD $10.68
- 52 Week High
- CDXS $6.08
- NETD $11.47
- Technical
- Relative Strength Index (RSI)
- CDXS 31.30
- NETD 55.86
- Support Level
- CDXS $2.52
- NETD $11.29
- Resistance Level
- CDXS $2.80
- NETD $11.38
- Average True Range (ATR)
- CDXS 0.14
- NETD 0.03
- MACD
- CDXS -0.06
- NETD -0.00
- Stochastic Oscillator
- CDXS 1.54
- NETD 54.55
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About NETD Nabors Energy Transition Corp. II
Nabors Energy Transition Corp II is a blank check company.